Stem Cell Technology for Embryotoxicity, Cardiotoxicity, and Hepatotoxicity Evaluation

Drug Efficacy, Safety, and Biologics Discovery: Emerging Technologies and Tools

Volumn , Issue , 2008, Pages 175-213

  Davila, Julio C ^a   Stedman, Donald B ^a   Engle, Sandra J ^a   Pryor, Howard I ^b   Vacanti, Joseph P ^b  

^a PFIZER INC   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Stem cell technology for cardiotoxicity evaluation; Stem cell technology for embryotoxicity evaluation; Stem cell technology for hepatotoxicity evaluation

Indexed keywords

EID: 84889691506     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470431818.ch8     Document Type: Chapter

References (175)

1. Lasser K, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002; 287: 2215-20.
2. Schuster D, Laggner C, Langer T. Why drugs fail-study on side effects in new chemical entities. Curr Pharm Des 2005; 11: 3545-59.
3. Wysowski DK, Swartz L. Adverse drug event survillance and drug withdrawals in the United States. Arch Intern Med 2005; 165: 1363-9.
4. Dambach DM, Andrews BA, Moulin F. New technologies and screening strategies for hepatotoxicity: use of in vitro models. Toxicol Pathol 2005; 33:17-26.
5. Davila JC, Rodrigues RJ, Melchert RB, Acosta D. Predicitive value of in vitro model systems in toxicology. Ann Rev Pharmacol Toxicol 1998; 38: 63-96.
6. Davila JC, Xu JJ, Hoffmaster KA, O'Brien PJ, Strom S. Current in vitro models to study drug-induced liver injury. In Sahu S, ed. Hepatotoxicity: from genomics to in vitro and in vivo models. Hoboken, NJ: Wiley, 2007. p. 1-30.
7. Cezar G. Embryonic stem cells: a new avenue to evaluate the effects of chemicals in humans. Int J Pharm Med 2006; 20: 107-14.
8. Davila JC, Cezar GG, Thiede M, Strom S, Miki T, Trosko J. Use and application of stem cells in toxicology. Tox Sci 2004; 79: 214-23.
9. McNeish J. Embryonic stem cells in drug discovery. Nat Rev Drug Discov 2004; 3: 70-80.
10. Poulton CW, Haynes J. Embryonic stem cells as a source of models for drug discovery. Nat Rev Drug Discov 2007; 6: 605-16.
11. Ameen C, Raimund S, Bjorquist P, Lindahl A, Hyllner J, Sartipy P. Human embryonic stem cells: current technologies and emerging industrial applications. Crit Rev Oncol Hematol 2008; 65: 54-80.
12. Mayne J, Ku W, Kennedy S. Informed toxicity assessment in drug discovery:systems-based toxicology. Curr Opin Drug Discov Dev 2006; 9: 75-83.
13. Sartipy P, Bjorquist P, Strehl R, Hyllner J. Pluripotent human stem cells a novel tools in drug discovery and toxicity testing. I Drugs 2006; 9: 702-5.
14. Evans MJ, Kaufmann M. Establishment in culture of pluripotent cells from mouse embryos. Nature 1981; 292: 154-6.
15. Abuin A, Holt KH, Platt KA, Sands AT, Zambrowicz B. Full-speed mammalian genetics: in vivo target validation in the drug discovery process. Trends Biotechnol 2002; 20: 261-8.
16. Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel C. Deficiency of the stress kinase p38a results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med 2000; 191: 859-70.
17. Harris S. Transgenic knockouts as part of high-throughput, evidence based taget selection and validation strategies. Drug Discov Today 2001; 6: 628-36.
18. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981; 78: 7634-8.
19. Zambrowicz BP, Sands A. Knockouts of the 100 best-selling drugs-will they model the next 100? Nat Rev Drug Discov 203; 2: 38-51.
20. Genschow E, Spielmann H, Scholz G, Pohl I, Seiler A, Clemann N, et al. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 2004; 32: 209-44.
21. Newal DR, Beedles K. The stem cell test: an in vitro assay for teratogenic potential. Results of a blind trial with 25 compounds. Tox In vitro 1996; 10:229-40.
22. Scholz G, Genschow E, Pohl I, Bremer S, Paparella M, Raabe H, et al. Prevalidation of the embryonic stem cell test (EST)-a new in vitro embryotoxicity test. Toxicol In vitro 1999; 13: 675-81.
23. Scholz G, Pohl I, Genschow E, Klemm M, Spielmann H. Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tiss Org 1999; 165: 203-11.
24. Thompson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-7.
25. Lavon N, Benvenistry N. Study of hepatocyte differentiation using embryonic stem cells. J Cell Biochem 2005; 96: 1193-202.
26. Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Chen Y. Differentiation of human embryonic stem cells to hepatocytes using deleted variant of HGF and poly-amino-urethane-coated nonwoven polytetrafluoroethylene fabric. Cell Transpl 2006; 15: 335-41.
27. Xu C, Police S, Rao N, et al. Characterization and enrichment cardiomyocytes derived from human embryonic stem cells. Cir Res 2002; 91: 501-8.
28. Leahy A, Xiong JW, Kuhnert F, Stuhlmann H. Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation. J Exp Zool 1999; 284: 67-81.
29. Rohwedel J, Guan K, Hegert C, Wobus AM. Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies: present state and future prospects. Toxicol In vitro 2001; 15: 741-53.
30. Laschinski G, Vogel R, Spielmann H. Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening. Reprod Toxicol 1991; 5: 57-64.
31. Brown NA. Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. ATLA 2002; 30: 177-98.
32. Chapin R, Stedman D, Paquette J, Streck R, Kumpf S, Deng S. Struggles for equivalence: In vitro developmental toxicity model evolution in pharmaceuticals in 2006. Toxicol In vitro 2007; 21: 1545-51.
33. Bremer S, Worth AP, Paparella M, Bigot K, Kolossov E, Fleischmann BK, Hescheler J, Balls M. Establishment of an in vitro reporter gene assay for developmental cardiac toxicity. Toxicol In vitro 2001; 15: 215-23.
34. Bigot K, De Lange J, Archer G, Clothier R, Bremer S. The relative semi -quantification of mRNA expression as a useful toxicological endpoint for the identification of embryotoxic/teratogenic substances. Toxicol In vitro 1999; 13:619-23.
35. Zur Nieden NI, Ruf LJ, Kempka G, Hildebrand H, Ahr H. Molecular markers in embryonic stem cells. Toxicol In vitro 2001; 15: 455-61.
36. zur Nieden NI, Kempka G, Ahr HJ. Molecular multiple endpoint embryonic stem cell test-a possible approach to test for the teratogenic potential of compounds. Toxicol Appl Pharmacol 2004; 194: 257-69.
37. Pellizzer C, Adler S, Corvi R, Hartung T, Bremer S. Monitoring of teratogenic effects in vitro by analysing a selected gene expression pattern. Toxicol In vitro 2004; 18: 325-35.
38. Dvash T, Mayshar Y, Darr H, McElhaney M, Barker D, Yanuka O, et al. Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Hum Reprod 2004; 19: 2875-83.
39. Festag M, Viertel B, Steinberg P, Sehner C. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II: testing of compounds. Toxicol In vitro 2007; 21:1631-40.
40. Zhang B, Pan X, Anderson TA. MicroRNA: a new player in stem cells. J Cell Physiol 2006; 209: 266-9.
41. Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Reg Toxicol Pharmacol 2000; 32: 56-67.
42. Slordal L, Spigset O. Heart failure induced by no-cardiac drugs. Drug Saf 2006; 29: 567-86. http://www.ich.org.
43. Arrigoni C, Crivori P. Assessment of QT liabilities in drug development. Cell Biol Toxicol 2007; 23: 87-105.
44. Fermini B, Fossa A. The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov 2003; 2: 429-47.
45. Hoffmann P, Warner B. Channel inhibition and QT interval prolongation: all there is in drug-induced torsadogenesis? Toxicol Meth 2006; 53: 87-105.
46. Harding SE, Ali NN, Brito-Martins M, et al. The human embryonic stem cell-derived cardiomyocytes as a pharmacological model. Pharmacol Ther 2007; 113: 341-53.
47. Mitcheson JS, Hancox JC, Levi A. Cultured adult cardiac myocytes: Future applications, culture methods, morpological and electrophysiological properties. Cardiovas Res 1998; 39: 280-300.
48. Piper H, Jacobson S, Schwartz P. Determinants of cardiomyocyte development in long-term primary culture. J Mol Cell Cardiol 1998; 20: 825-35.
49. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell Biol Toxicol 2003; 114:763-76.
50. Urbanek K, Quani F, Giordano T, et al. Intense myocyte formation from cardiac stem cell in human cardiac hyperthrophy. Proc Natl Acad Sci USA 2003; 100:10440-5.
51. Urbanek K, Torella D, Sheikh F, et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA 2005; 102: 8692-7.
52. Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells. Proc Natl Acad Sci USA 2007; 104: 14068-73.
53. Chen X, Wilson RM, Kubo H, et al. Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties . Circ Res 2007; 100: 536-44.
54. Linke A, Muller P, Nurzynska D, et al. Stem cells in the dog heart are self -renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 2005; 102: 8966-71.
55. Matsuura K, Nagai T, Nishigaki N, et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004; 279: 11384-91.
56. Messina E, Angelis De L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95: 911-21.
57. Laugwitz K, Moretti A, Lam J, et al. Postnatal isl1 cardioblasts enter fully differentated cardiomyocyte lineages. Nat Biotechnol 2005; 433: 647-53.
58. Cai C, Liang X, Shi Y, et al. Isi1 identifies a cardiac progenitor population that proliferates prior to differentation and contributes a majority of cells to the heart. Dev Cell 2003; 5: 877-89.
59. Bobbis S, Jarocha D, Majka M. Mesenchymal stem cells: charateristics and clinical applicaitons. Folia Histochem Cytobiol 2003; 44: 215-30.
60. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cell in vitro. J Clin Invest 1999; 103: 697-705.
61. Rangappa S, Entwistle J, Wechsler A, et al. Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardiovasc Surg 2003; 126: 124-32.
62. Shim W, Jiang S, Wong P, et al. Ex vivo differentiaiton of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 2004; 324: 481-8.
63. Hakuno D, Fukuda K, Makino S, et al. Bone marrow-derived regenerated cardiomyocytes (CMG cells) express functional adrenergic and muscarinic receptors. Circulation 2002; 105: 380-6.
64. Kajstura J, Rota M, Whang B, et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Cir Res 2004; 96:127-37.
65. Tomita S, Li RK, Weisel RD, et al. Autologous transportation of bone marrow cells improves damaged heart function. Circulation 1999; 100: II247-56.
66. Collins SD, Baffour R, Waksman R. Cell therapy in myocardial infarction. Cardiovasc Rvasc Med 2000; 8: 43-51.
67. Palpant NJ, Yasuda S, MacDougald O, et al. Non-canonical Wnt signaling enhances differentiation of Sca1+/C-kit adipose-derived murine stromal vascular cells into spontaneously beating cardiac myocytes. J Mol Cell Cardio 2007; 43:363-70.
68. Planat-Benard V, Menard C, Andre M, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stromal cells. Circ Res 2004; 94: 223-9.
69. Rangappa S, Fen C, Lee E, et al. Transformation of adult mesenchymal stem cells isolated from fatty tissue into cardiomyocytes. Ann Thorac Surg 2003; 75: 775-9.
70. Winitsky SO, Gopal TV, Hassanzadeh S, et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomypcytes in vitro. PLoS Biol 2005; 3: e87.
71. Badorff C, Brandes RP, Popp R, et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003; 107: 1024-32.
72. Bonanno G, Mariotti A, Procoli A, et al. Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial -and cardiomyocyte-like cells. Transfusion 2007; 47: 280-9.
73. Kadivar M, Khatami S, Mortazavi Y, et al. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun 2006; 340: 639-47.
74. Nishiyama N, Miyoshi S, Hidan N, et al. The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells 2007; 10: 2006-0662.
75. Miki T, Lehmann T, Cai H, Stolz DB, Strom S. Stem cells characteristics of amniotic epithelial cells. Stem Cells 2005; 23: 1549-59.
76. Okamoto K, Miyoshi S, Toyoda M, et al. Working cardiomyocyte exhibiting plateau action potentials from human placenta-derived extraembryonic mesodermal cells. Exp Cell Res 2007; 313: 2550-62.
77. De Coppi P, Bartsch G, Siddiqui M, et al. Isolation of ammiotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25: 100-6.
78. Kehat I, Kenyagin-Karsenti D, Snir N, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes . J Clin Invest 2001; 108: 407-14.
79. Mummery C, Ward-Van O, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture visceral endoderm-like cells. Circulation 2003; 107: 2733-40.
80. Sartiani L, Bettiol E, Stillitano F, et al. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells. Stem Cells 2007; 25: 1136-44.
81. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25: 1015-24.
82. Van Laake LW, Rassier R, Monshouwer-Kloots J, et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transciently improve function after myocardial infarction. Stem Cell Res 2007; 10:1016.
83. Kehat I, Gepstein A, Spira A, et al. High-resolution electrophysiological assessment of human embryonic stem cells derived-cardiomyocytes: a novel in vitro model for the study of conduction. Cir Res 2002; 91: 659-61.
84. Reppel M, Pillekamp F, Brockmeier K, et al. The electrocardiogram of human embryonic stem cell-derived cardiomyocytes. J Electrocardiol 2005; 38: 166-70.
85. Beqqali A, Kloots J, Ward-Van O, et al. Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells 2006; 24: 1956-67.
86. Huber I, Itzhaki I, Caspi O, et al. Identification of selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB 2007; 21: 2551-63.
87. Anderson D, Self T, Mellor IR, et al. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther 2007; 15: 2027-36.
88. Zwaka TP, Thompson JA. Homologous recombination in human embryonic stem cells. Nat Biotechnol 2003; 21: 1319-21.
89. Alperin C, Zandstra PW, Woodhouse KA. Engineering cardiac healing using embryonic stem cell-derived cardiac cell seeded constructs. Front Biosci 2007; 12:3694-712.
90. Feinberg AW, Feigel A, Shevkolyas SS, et al. Muscular thin films for building actuators and power devices. Science 2007; 317: 1366-70.
91. Caspi O, Lesman A, Basevitch Y, et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 2007; 100: 263-72.
92. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev 2007; 7: 1121-30.
93. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22:1282-9.
94. Suter L, Babiss LE, Wheeldon E. Toxicogenomics in predictive toxicology in drug development. Chem Biol 2004; 11: 161-71.
95. Farkas D, Tannembaum S. In vitro methods to study chemically-induced hepatotoxicity:a literature review. Curr Drug Metab 2005; 6: 111-25.
96. Grisham JW, Charlton RK, Kaufman DG. In vitro assay of cytotoxicity with cultured liver: accomplishments and possibilities. Environ Health Perspect 1978; 25:161-71.
97. Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. Philadelphia: Lippincott Williams Wilkins, 1999.
98. Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis 2000; 4: 73-96.
99. Dambach DM, Andrews BA, Moulin F. New technologies and screening strategies for hepatotoxicity: use of in vitro models. Toxicol Pathol 2005; 33: 17-26.
100. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981; 78: 7634-8.
101. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292: 154-6.
102. Scherer CA, Chen J, Nachabeh A, Hopkins N, Ruley HE. Transcriptional specificity of the pluripotent embryonic stem cell. Cell Growth Differ 1996; 7:1393-401.
103. Beddington RS, Robertson EJ. An assessment of the developmental potential of embryonic stem cells in the midgestation mouse embryo. Development 1989; 105:733-7.
104. Abe K, Niwa H, Iwase K, Takiguchi M, Mori M, Abe SI, et al. Endoderm-specific gene expression in embryonic stem cells differentiated to embryoid bodies. Exp Cell Res 1996; 229: 27-34.
105. Levinson-Dushnik M, Benvenisty N. Involvement of hepatocyte nuclear factor 3 in endoderm differentiation of embryonic stem cells. Mol Cell Biol 1997; 17:3817-22.
106. Jones EA, Tosh D, Wilson DI, Lindsay S, Forrester LM. Hepatic differentiation of murine embryonic stem cells. Exp Cell Res 2002; 272: 15-22.
107. Yamada T, Yoshikawa M, Kanda S, Kato Y, Nakajima Y, Ishizaka S, et al. In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells 2002; 20: 146-54.
108. Asahina K, Fujimori H, Shimizu-Saito K, Kumashiro Y, Okamura K, Tanaka Y, et al. Expression of the liver-specific gene Cyp7a1 reveals hepatic differentiation in embryoid bodies derived from mouse embryonic stem cells. Genes Cells 2004; 9: 1297-308.
109. Hamazaki T, Iiboshi Y, Oka M, Papst PJ, Meacham AM, Zon LI, et al. Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett 2001; 497:15-9.
110. Kuai XL, Cong XQ, Li XL, Xiao SD. Generation of hepatocytes from cultured mouse embryonic stem cells. Liver Transpl 2003; 9: 1094-9.
111. Kubo A, Shinozaki K, Shannon JM, Kouskoff V, Kennedy M, Woo S, et al. Development of definitive endoderm from embryonic stem cells in culture. Development 2004; 131: 1651-62.
112. Yamamoto H, Quinn G, Asari A, Yamanokuchi H, Teratani T, Terada M, et al. Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application. Hepatology 2003; 37: 983-93.
113. Teratani T, Yamamoto H, Aoyagi K, Sasaki H, Asari A, Quinn G, et al. Direct hepatic fate specification from mouse embryonic stem cells. Hepatology 2005; 41:836-46.
114. Yamamoto Y, Teratani T, Yamamoto H, Quinn G, Murata S, Ikeda R, et al. Recapitulation of in vivo gene expression during hepatic differentiation from murine embryonic stem cells. Hepatology 2005; 42: 558-67.
115. Fair JH, Cairns BA, Lapaglia M, Wang J, Meyer AA, Kim H, et al. Induction of hepatic differentiation in embryonic stem cells by co-culture with embryonic cardiac mesoderm. Surgery 2003; 134: 189-96.
116. Hu A, Cai J, Zheng Q, He X, Pan Y, Li L. Hepatic differentiation from embryonic stem cells in vitro. Chin Med J (Engl) 2003; 116: 1893-7.
117. Ishii T, Yasuchika K, Fujii H, Hoppo T, Baba S, Naito M, et al. In vitro differentiation and maturation of mouse embryonic stem cells into hepatocytes. Exp Cell Res 2005; 309: 68-77.
118. Ishizaka S, Ouji Y, Yoshikawa M, Nakatani K. Derivation and characterization of hepatocytes from embryonic stem cells in vitro. Meth Mol Biol 2006; 330:387-99.
119. Novik EI, Maguire TJ, Orlova K, Schloss RS, Yarmush ML. Embryoid body -mediated differentiation of mouse embryonic stem cells along a hepatocyte lineage: insights from gene expression profiles. Tissue Eng 2006; 12: 1515-25.
120. Soto-Gutierrez A, Navarro-Alvarez N, Zhao D, Rivas-Carrillo JD, Lebkowski J, Tanaka N, et al. Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines. Nat Protoc 2007; 2: 347-56.
121. Choi D, Oh HJ, Chang UJ, Koo SK, Jiang JX, Hwang SY, et al. In vivo differentiation of mouse embryonic stem cells into hepatocytes. Cell Transpl 2002; 11:359-68.
122. Tsutsui M, Ogawa S, Inada Y, Tomioka E, Kamiyoshi A, Tanaka S, et al. Characterization of cytochrome P450 expression in murine embryonic stem cell -derived hepatic tissue system. Drug Metab Dispos 2006; 34: 696-701.
123. Xu JJ, Diaz D, O'Brien PJ. Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential. Chem Biol Interact 2004; 150: 115-28.
124. Thompson JA, Kalishman J, Golos TG, Durning M, Harris CP, Becker RA, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci USA 1995; 92: 7844-8.
125. Marshall E. Cell biology: a versatile cell line raises scientific hopes, legal questions . Science 1998; 282: 1014-5.
126. Gearhart J. Cell biology: new potential for human embryonic stem cells. Science 1998; 282: 1061-2.
127. Miller LJ, Bloom FE. Publishing controversial research. Science 1998; 282:1045.
128. Hart AH, Hartley L, Ibrahim M, Robb L. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn 2004; 230: 187-98.
129. Heins N, Englund MC, Sjoblom C, Dahl U, Tonning A, Bergh C, et al. Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 2004; 22: 367-76.
130. Laslett AL, Filipczyk AA, Pera M. Characterization and culture of human embryonic stem cells. Trends Cardiovasc Med 2003; 13: 295-301.
131. Park SP, Lee YJ, Lee KS, Ah-Shin H, Cho H. Establishment of human embryonic stem cell lines from frozen-thawed blastocysts using STO cell feeder layers. Hum Reprod 2004; 19: 676-84.
132. Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 2000; 6: 88-95.
133. Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2000; 97: 11307-12.
134. Kobayashi N, Okitsu T, Tanaka N. Cell choice for bioartificial livers. Keio J Med 2003; 52: 151-7.
135. Rambhatla L, Chiu CP, Kundu P, Peng Y, Carpenter MK. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transpl 2003; 12:1-11.
136. Sinha G. Cell biology. Human embryonic stem cells may be toxicology's new best friends. Science 2005; 308: 1538.
137. Haumaitre C, Reber M, Cereghini S. Functions of HNF1 family members in differentiation of the visceral endoderm cell lineage. J Biol Chem 2003; 278:40933-42.
138. Lavon N, Yanuka O, Benvenisty N. Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation 2004; 72: 230-8.
139. Chen Y, Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Yamatsuji T, Shirakawa Y, et al. Instant hepatic differentiation of human embryonic stem cells using activin A and a deletedvariant of HGF. Cell Transpl 2006; 15: 865-71.
140. Heng BC, Yu H, Yin Y, Lim SC, Cao T. Factors influencing stem cell differentiation into the hepatic lineage in vitro. J Gastroenterol Hepatol 2005; 20.
141. Schwartz RE, Linehan JL, Painschab MS, Hu WS, Verfaillie CM, Kaufman D. Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev 2005; 14: 643-55.
142. Tsukada H, Takada T, Shiomi H, Torii R, Tani T. Acidic fibroblast growth factor promotes hepatic differentiation of monkey stem cells. In vitro Cell Dev Biol 2006; 42: 83-8.
143. Newsome PN, Johannessen I, Boyle S, Dalakas E, McAulay KA, Samuel K, et al. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology 2003; 124:1891-900.
144. Di Campli C, Piscaglia AC, Pierelli L, Rutella S, Bonanno G, Alison MR, et al. A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. Dig Liver Dis 2004; 36: 603-13.
145. Di Campli C, Piscaglia AC, Rutella S, Bonanno G, Vecchio FM, Zocco MA, et al. Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. Transpl Proc 2005; 37: 2707-10.
146. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103:1669-75.
147. Matikainen T, Laine J. Placenta-an alternative source of stem cells. Toxicol Appl Pharmacol 2005; 207: 544-9.
148. McGuckin CP, Forraz N, Baradez MO, Navran S, Zhao J, Urban R, et al. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif 2005; 38: 245-55.
149. Saito S, Yokoyama K, Tamagawa T, Ishiwata I. Derivation and induction of the differentiation of animal ES cells as well as human pluripotent stem cells derived from fetal membrane. Hum Cell 2005; 18: 135-41.
150. Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH, et al. In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun 2005; 330:1153-61.
151. Kang XQ, Zang WJ, Bao LJ, Li DL, Song TS, Xu XL, et al. Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes. World J Gastroenterol 2005; 11: 7461-5.
152. Kang XQ, Zang WJ, Bao LJ, Li DL, Xu XL, Yu XJ. Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro. Cell Biol Int 2006; 30: 569-75.
153. Teramoto K, Asahina K, Kumashiro Y, Kakinuma S, Chinzei R, Shimizu-Saito K, et al. Hepatocyte differentiation from embryonic stem cells and umbilical cord blood cells. J Hepatobiliary Pancreat Surg 2005; 12: 196-202.
154. Chien CC, Yen BL, Lee FK, Lai TH, Chen YC, Chan SH, et al. In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells 2006; 24: 1759-68.
155. Sun Y, Xiao D, Zhang RS, Cui GH, Wang XH, Chen XG. Formation of human hepatocyte-like cells with different cellular phenotypes by human umbilical cord blood-derived cells in the human-rat chimeras. Biochem Biophys Res Commun 2007; 357: 1160-5.
156. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990; 110: 1001-20.
157. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002; 109: 1291-302.
158. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284:1168-70.
159. Fuchs E, Segre JA. Stem cells: a new lease on life. Cell 2000; 100: 143-55.
160. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999; 283: 534-7.
161. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004; 14: 311-24.
162. Shu SN, Wei L, Wang JH, Zhan YT, Chen HS, Wang Y. Hepatic differentiation capability of rat bone marrow-derived mesenchymal stem cells and hematopoietic stem cells. World J Gastroenterol 2004; 10: 2818-22.
163. Lange C, Bassler P, Lioznov MV, Bruns H, Kluth D, Zander AR, et al. Hepatocytic gene expression in cultured rat mesenchymal stem cells. Transpl Proc 2005; 37: 276-9.
164. Shimomura T, Yoshida Y, Sakabe T, Ishii K, Gonda K, Murai R, et al. Hepatic differentiation of human bone marrow-derived UE7T-13 cells:effects of cytokines and CCN family gene expression. Hepatol Res 2007; 37: 1068-79.
165. Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M, et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005; 106: 756-63.
166. Aurich I, Mueller LP, Aurich H, Luetzkendorf J, Tisljar K, Dollinger MM, et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 2007; 56: 405-15.
167. Oh SH, Witek RP, Bae SH, Zheng D, Jung Y, Piscaglia AC, et al. Bone marrow -derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration. Gastroenterology 2007; 132:1077-87.
168. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. H uman adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13:4279-95.
169. Seo MJ, Suh SY, Bae YC, Jung JS. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 2005; 328: 258-64.
170. Talens-Visconti R, Bonora A, Jover R, Mirabet V, Carbonell F, Castell JV, et al. Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J Gastroenterol 2006; 12: 5834-45.
171. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G, et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes . Hepatology 2007; 46: 219-28.
172. Sgodda M, Aurich H, Kleist S, Aurich I, Konig S, Dollinger MM, et al. Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res 2007; 313: 2875-86.
173. Asahina K, Fujimori H, Shimizu-Saito K, Kumashiro Y, Okamura K, Tanaka Y, et al. Expression of the liver-specific gene Cyp7a1 reveals hepatic differentiation in embryoid bodies derived from mouse embryonic stem cells. Genes Cells 2004; 9: 1297-308.
174. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;doi:10.1126.Science 1151526.
175. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 1-12.